NCT07426263

Brief Summary

Cardiovascular disease is the leading cause of morbidity and mortality among women and is frequently associated with changes in sexual function, emotional distress, and reduced quality of life. In women, these difficulties are often influenced by gender-specific factors, including differences in clinical presentation, psychosocial roles, caregiving responsibilities, and the historical under-recognition of female sexuality within cardiovascular care. Although international clinical recommendations highlight the importance of addressing sexual health as part of comprehensive cardiac rehabilitation, this aspect remains insufficiently integrated into routine practice, particularly from a female-centered perspective. This randomized controlled trial aims to evaluate the effectiveness of a Therapeutic Education Program on Female Sexuality (PET-SF), specifically designed and implemented within a hospital-based cardiac rehabilitation unit. The program is delivered as a structured, group-based, nurse-led educational intervention integrated into usual care. The primary outcome is female sexual function, while secondary outcomes include anxiety, depression, quality of life, and medication adherence. The study seeks to determine whether a gender-sensitive therapeutic education approach can improve sexual well-being and related psychosocial outcomes in women attending cardiac rehabilitation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P25-P50 for not_applicable cardiovascular-diseases

Timeline
12mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Feb 2026May 2027

First Submitted

Initial submission to the registry

February 16, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

February 18, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 23, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2027

Last Updated

May 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1.2 years

First QC Date

February 16, 2026

Last Update Submit

May 12, 2026

Conditions

Keywords

Sexual educationSexualityWomenCardiovascular diseasesCardiac rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Female Sexual Function

    Instrument: Female Sexual Function Index (FSFI-19). The Female Sexual Function Index is a validated 19-item questionnaire assessing six domains of female sexual function over the previous four weeks: desire, arousal, lubrication, orgasm, satisfaction, and pain. The total score ranges from 2 to 36, with higher scores indicating better sexual function (less dysfunction and less pain). A total score of ≤26-26.55 is commonly used as a threshold suggestive of sexual dysfunction. Clinical improvement will be interpreted as a change from a baseline score \<26 to ≥26 and/or a moderate effect size (≥0.5) in score change over time, in accordance with established interpretation guidelines.

    Change from baseline (T0) to follow-up (T2, 12-13 weeks)

Secondary Outcomes (3)

  • Hospital Anxiety and Depression

    Change from baseline (T0) to follow-up (T2, 12-13 weeks)

  • Health-related quality of life

    Change from baseline (T0) to follow-up (T2, 12-13 weeks)

  • Treatment adherence

    Change from baseline (T0) to follow-up (T2, 12-13 weeks)

Study Arms (2)

Intervention group

EXPERIMENTAL

The experimental group will receive the Therapeutic Education Program on Female Sexuality (PET-SF) in addition to usual cardiac care. PET-SF is a structured, nurse-led, group intervention specifically for women with cardiovascular disease. It consists of four sessions over two weeks within the cardiac rehabilitation unit. Grounded in the EX-PLISSIT model, the program addresses clinical and psychosocial dimensions of sexuality after a cardiovascular event. Core components include sexual safety, the impact of conditions and pharmacological treatments on sexual function, emotional and relational aspects, communication skills, and practical recommendations for the safe resumption of sexual activity. Sessions are group-based and integrated into the standard rehabilitation schedule.

Behavioral: Therapeutic Education Program on Female Sexuality (PET-SF)Behavioral: Usual Care

Control group

ACTIVE COMPARATOR

All participants enrolled in the study will receive standard multidisciplinary cardiac rehabilitation care as routinely provided in the hospital-based program. Usual care includes supervised physical training, cardiovascular risk factor management, lifestyle counselling, medical follow-up, and general health education. The standard rehabilitation program does not include a structured or gender-specific intervention specifically addressing female sexuality. Sexual health topics may be mentioned as part of general counselling, but no dedicated sessions focused on female sexual function are routinely provided.

Behavioral: Usual Care

Interventions

The PET-SF is a structured, nurse-led, group-based therapeutic education program specifically developed for women undergoing cardiac rehabilitation. Unlike general cardiac education or brief counselling approaches, PET-SF focuses exclusively on female sexuality after cardiovascular disease and integrates clinical safety information with psychosocial and relational dimensions. The program is delivered in four structured sessions over approximately two weeks and is grounded in an educational framework inspired by the EX-PLISSIT model. It combines evidence-based information, normalization of concerns, communication skill development, and practical guidance to support safe resumption of sexual activity within a gender-sensitive approach integrated into routine cardiac rehabilitation.

Intervention group
Usual CareBEHAVIORAL

Participants allocated to the control group will receive usual care as provided within the standard cardiac rehabilitation program. Usual care includes multidisciplinary cardiovascular rehabilitation focusing on physical training, cardiovascular risk factor management, lifestyle modification, and medical follow-up. The control group will not receive the structured PET-SF educational intervention during the main study period. After completion of follow-up assessments, participants in the control group will be offered the opportunity to participate in the PET-SF program.

Control groupIntervention group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women will be eligible to participate if they meet all of the following criteria:
  • Female sex.
  • Age 18 years or older.
  • Referral to a hospital-based Cardiac Rehabilitation Unit following a cardiovascular event.
  • Clinical stability and medical clearance to participate in the cardiac rehabilitation program.
  • Ability to understand the study information and provide written informed consent.

You may not qualify if:

  • Women will be excluded if any of the following criteria apply:
  • Severe cognitive impairment or language barriers that preclude understanding of the intervention or study procedures.
  • Recent participation in structured sexual education or sexual counselling programs.
  • Inability to attend the sessions assigned within the intervention period.
  • Attendance at fewer than two sessions of the intervention program.
  • Occurrence of clinical complications or hospital readmission during the study period that prevent continued participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Virgen Macarena University Hospital. Seville (Spain)

Seville, 41020, Spain

Location

MeSH Terms

Conditions

Cardiovascular DiseasesSexuality

Condition Hierarchy (Ancestors)

Sexual BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2026

First Posted

February 23, 2026

Study Start

February 18, 2026

Primary Completion (Estimated)

May 19, 2027

Study Completion (Estimated)

May 19, 2027

Last Updated

May 13, 2026

Record last verified: 2026-02

Locations